What is the success rate of stem cell therapy for Arterial Hypertension?
No validated stem-cell success rate exists for hypertension. Review ambulatory or standardised blood-pressure outcomes, medication changes, comparator, cardiovascular and kidney events, adverse effects and duration rather than a single office reading.
What the evidence shows for Arterial Hypertension
Blood pressure requires repeated valid measurement and assessment of cardiovascular risk and secondary causes. The NHLBI treatment overview describes heart-healthy lifestyle measures, monitoring and medicines. Experimental biomarker or endothelial findings do not show fewer strokes, heart attacks, kidney events or deaths, and must not justify stopping prescribed treatment.
Am I a candidate? → · Arterial Hypertension: full overview → · Arterial Hypertension cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Arterial Hypertension: cell-therapy evidence and registered trials
- How much does stem cell therapy for Arterial Hypertension cost? (2026)
- Arterial Hypertension stem cell therapy — your questions answered (2026)
- Arterial Hypertension: cell-therapy evidence by therapy class
- MSC vs exosomes for Arterial Hypertension: what the registries show